Benzinga - Gainers
- ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) shares rose 82.8% to $2.98 in pre-market trading. ZyVersa Therapeutics recently reported new employment inducement grants under Nasdaq Listing Rule 5635(c)(4).
- Advent Technologies Holdings, Inc. (NASDAQ: ADN) climbed 26.4% to $1.53 in pre-market trading. Hyundai Motor Company and Advent Technologies signed a joint development agreement following successful fuel cell technology assessment.
- Boxed, Inc. (NYSE: BOXD) gained 19% to $0.2140 in pre-market trading after gaining around 50% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankruptcy Code and other strategic alternatives.
- YS Biopharma Co., Ltd. (NASDAQ: YS) gained 16% to $8.11 in pre-market trading after dropping 8% on Wednesday.
- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) shares rose 15.4% to $4.25 in pre-market trading after dropping more than 7% on Wednesday.
- Agile Therapeutics, Inc. (NASDAQ: AGRX) gained 14.3% to $0.3030 in pre-market trading following better-than-expected Q4 results.
- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) rose 13.8% to $0.33 in pre-market. Bellicum Pharmaceuticals shares fell over 8% on Wednesday after the company discontinued Phase 1/2 trials and initiated an evaluation of strategic alternatives.
- Bird Global, Inc. (NYSE: BRDS) shares rose 12.7% to $0.1360 in pre-market trading after dropping around 7% on Wednesday. Bird recently received additional funding, bringing total capital to $33 million this year.
- Aziyo Biologics, Inc. (NASDAQ: AZYO) rose 12.6% to $1.34 in pre-market trading after posting upbeat Q4 results.
- Lion Group Holding Ltd. (NASDAQ: LGHL) shares rose 12.1% to $0.2790 in pre-market trading after adding around 4% on Wednesday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Minim, Inc. (NASDAQ: MINM) fell 12.4% to $0.1375 in pre-market trading after gaining 17% on Wednesday. The company is expected to report Q4 results on March 29, 2023.
- Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares dropped 8.7% to $0.95 in pre-market trading. Heart Test Laboratories, last week, posted a Q3 loss of $0.16 per share.
- Coinbase Global, Inc. (NASDAQ: COIN) fell 8.4% to $70.70 in pre-market trading after the company received a Wells Notice from the SEC alleging violations of federal securities laws in regards to the company's spot market and staking service.
- VYNE Therapeutics Inc. (NASDAQ: VYNE) fell 8.4% to $2.32 in pre-market after dropping more than 6% on Wednesday. VYNE Therapeutics recently posted a narrower-than-expected quarterly loss.
- Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) fell 8% to $0.6716 in pre-market trading after gaining more than 13% on Wednesday.
- Chewy, Inc. (NYSE: CHWY) shares fell 6.6% to $35.26 in pre-market trading. Chewy reported better-than-expected earnings and sales results for its fourth quarter. However, the company's active customers came in at 20.4 million, down 1.2% from a year ago.
- INVO Bioscience, Inc. (NASDAQ: INVO) fell 6.4% to $0.7619 in pre-market trading after jumping over 28% on Wednesday. INVO recently signed binding agreements to acquire Wisconsin Fertility Institute.
- Cidara Therapeutics, Inc. (NASDAQ: CDTX) shares fell 6.3% to $1.78 in pre-market trading. Cidara Therapeutics and Melinta Therapeutics announced the FDA approval of REZZAYO for the treatment of candidemia and invasive candidiasis.
- Sarcos Technology and Robotics Corporation (NASDAQ: STRC) fell 6% to $0.40 in pre-market trading after gaining around 7% on Wednesday. Sarcos Technology recently posted upbeat quarterly results.
- EZGO Technologies Ltd. (NASDAQ: EZGO) fell 5% to $1.34 in pre-market trading after gaining over 33% on Wednesday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.